Dot1L-IN-2 structure
|
Common Name | Dot1L-IN-2 | ||
|---|---|---|---|---|
| CAS Number | 1940206-71-2 | Molecular Weight | 476.53 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C27H24N8O | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Dot1L-IN-2Dot1L-IN-2 is a potent, selective and orally bioavailable inhibitor of Dot1L (a histone methyltransferase), with an IC50 and Ki of 0.4 nM and 0.08 nM, respectively. |
| Name | Dot1L-IN-2 |
|---|
| Description | Dot1L-IN-2 is a potent, selective and orally bioavailable inhibitor of Dot1L (a histone methyltransferase), with an IC50 and Ki of 0.4 nM and 0.08 nM, respectively. |
|---|---|
| Related Catalog | |
| Target |
IC50: 0.4 nM (Dot1L)[1] Ki: 0.08 nM (Dot1L)[1] |
| In Vitro | Dot1L-IN-2 is a potent, selective Dot1L inhibitor, with an IC50 and Ki of 0.4 nM and 0.08 nM, respectively. Dot1L-IN-2 potently inhibits H3K79 dimethylation (IC50, 16 nM), and blocks the activity of the HoxA9 promoter (IC50, 340 nM) in cellular systems. Dot1L-IN-2 also dramatically suppresses proliferation of the human MLL-rearranged leukemia cell line MV4-11 carrying the oncogenic MLL-AF4 fusion (IC50, 128 nM)[1]. |
| References |
| Molecular Formula | C27H24N8O |
|---|---|
| Molecular Weight | 476.53 |